ESCRS Homepage

July 2003
IN THIS ISSUE
Ocular symptoms often the first sign of CMV-R in HIV- infected patients

When measuring quality of vision - scatter matters

Symposium to highlight ‘The next generation of IOLs'


Anti-HIV Drugs Save Vision of AIDS Patients


HIV is a risk factor for corneal ulceration


HIV-infection implicated in ischaemic maculopathy


Unexpected visual sensations may alarm surgical patients undergoing peribulbar anaesthesia


OHTS study shows that risk factor profiling can aid in treatment decisions for ocular hypertensives


Hi- tech centres boost care for glaucoma patients


OCT reliable, accurate technique for corneal thickness measurement


French survey shows changing practice patterns


Pre-op pupillometry reduces post-op unhappiness


French ophthalmology at a turning point?


US cataract surgeons change with the times


US LASIK market static but outlook good


Prosperity around the corner?


Russian mobile ophthalmic surgery unit brings relief to dispersed elderly population


Industry Briefs


Virtual reality lab boosts hi-tech vision research


Patients forget about two-thirds of doctors' treatment instructions, says neuropsychologist


Outlook on industry: Spin-off brings the best of both worlds


Incidence of wavefront aberrations varies widely in healthy eyes


FEATURES
From The Editor

Reflections on Refractive Surgery

Bio-Ophthalmology. From foe to friend: using HIV to treat genetic eye disease


Regulatory Matters. LASIK malpractice lawsuits establish European beachhead


Journal Watch. Vision science highlights from the world's leading journals of medicine and science


Intraocular antiseptic doubles as medium for Seidel testing


In your good books

 


Symposium to highlight 'The next Generation of IOLs'

 

WE hope you will be joining us for the XXI meeting of the ESCRS in the Bavarian capital of Munich in early September. Current registration rates suggest this will be the best-attended conference yet. Among the many incentives, the meeting offers four Main Symposia, each concentrating on a clinical topic suggested by our members.

This year's daily symposia will provide a detailed update and discussion of pseudoexfoliation, quality of vision after cataract and refractive surgery, new IOL designs, and lastly, hypermetropia.

The field of intraocular lens design is hot right now with many developments in the areas of multifocal and accommodative lenses, adjustable IOLs, phakic IOLs and lenses that improve quality of vision and reduce the incidence of PCO. Tuesday September 8th, nine renowned ophthalmologists from Europe and the United States will discuss some of the latest intraocular lenses to enter the clinic as well as some of those still in development.

Roberto Bellucci MD of the University of Verona, Italy and Jorge L. Alió, MD, PhD of the Instituto Oftalmológico de Alicante, Spain will co-chair the session on "The Next Generation of IOLs".

The advent of rollable and foldable IOLs made possible much smaller incisions, no stitch surgery and faster and better visual recovery.

Dr Alio will begin the session with a review of the latest microincision IOLs and the techniques used to implant them.

Wavefront sensing, more often associated with excimer laser refractive surgery, is also playing an increasing role in cataract surgery. Dr Bellucci will discuss how wavefront measurements can be used to evaluate IOL aberrations in vivo.

Howard Fine MD, of the Oregon Eye Surgery Center , Eugene , Oregon , USA was among the first to implant the Array multifocal lens in the US . He has since gained considerable experience with other multifocal and accommodative lenses. The former ASCRS president will provide an update on the newest concepts and models of multifocal IOLs.

Early IOL designs have achieved remarkable success in the correction of basic lower order aberrations but have done little to improve higher order visual aberrations. Ophthalmic surgeon and engineer Jack Holladay MD Houston Texas USA will be on hand to describe new IOL designs that compensate for higher order aberrations originating from the anterior corneal surface and the prospects for individualised IOLs based on wavefront profiling.

Charles Kelman MD, New York , USA is a true pioneer in ophthalmic surgery, having invented and developed the phacoemulsification process. He continues to develop new solutions to clinical challenges and will share his knowledge of innovative IOLs that allow the exchange of optics.

US surgeons, following the example set by their European colleagues, are very enthusiastic about the role of phakic IOLs in vision care. Richard Lindstrom MD, of Minneapolis , Minnesota is another well-known American pioneer in the field of ophthalmology. Dr Lindstrom will survey the field of phakic implants and will discuss several interesting products in the research and development pipeline.

Surgeons have long hoped for an IOL that could be adjusted to refine results or to take subsequent age-related changes into consideration. Nick Mamalis MD, Moran Eye Center , Salt Lake City , Utah will discuss the latest development in the area of adjustable IOLs.

There is growing evidence that IOL edge design can have a dramatic influence on posterior capsule opacification. Philippe Sourdille , MD , Clinique Sourdille, Nantes , France will discuss current issues surrounding IOL design and the prevention of PCO.

Finally, Manfred Tetz MD, Universitats-Augenklinik Charite, Berlin will provide a detailed analysis of pseudoaccommodation and IOL implantation.

Not registered yet? You will find the preliminary programme and online hotel and conference registration resources at our web site, www. escrs .org.